Recently, a shocking discovery has been made regarding the COVID-19 gene therapy products that have been marketed as vaccines. In an analysis of FDA documents, it has been revealed that these products have the ability to shed, cause cancer, and even kill individuals. This information suggests that the regulatory agencies were aware of these risks before the COVID-19 pandemic.
Firstly, it is important to understand that the COVID-19 injections are gene therapy, not traditional vaccines. The mRNA vaccines developed by Pfizer and Moderna do not contain antigens but instead use mRNA to provide instructions for producing spike proteins. This distinction is crucial in understanding the true nature of these products.
Furthermore, both Moderna and Pfizer have admitted in their SEC filings that their products are gene therapy. This acknowledgment raises questions about the misrepresentation of these products as vaccines. Additionally, a 2015 FDA guidance document defines gene therapy as products that mediate their effects through the transfer of genetic material, which aligns with the mechanism of action of the COVID-19 injections.
Another concerning aspect is the shedding of these gene therapy products. In a 2015 FDA document, it is stated that these products can be released from the body through excreta, secreta, or skin. This shedding raises the possibility of transmission from treated individuals to untreated individuals, posing a risk to those who did not consent to gene therapy.
Moreover, the FDA documents also reveal that these gene therapy products carry the risk of adverse effects on normal cell function and could potentially cause cancer. The integration of genetic material into the host genome and altered gene expression are among the concerns raised in these documents. This information contradicts the claims made by fact checkers that the COVID-19 injections do not affect or change DNA.
In a study analyzing the cellular DNA of individuals suffering from Long Covid, genes specific to the Pfizer COVID BNT162b2 vaccine were found in their blood cells. This finding provides evidence that mRNA COVID vaccines can permanently integrate into the DNA of vaccinated individuals.
The implications of these findings are alarming. The regulatory agencies were aware of the potential risks associated with these gene therapy products, including shedding, cancer, and delayed adverse events. The fact that these risks were not disclosed to the public raises ethical concerns and violates the principle of voluntary consent.
Furthermore, the increase in aggressive and fast-growing cancers among the vaccinated population is a cause for concern. Oncologists are reporting cases of cancers that do not respond to standard treatment protocols, indicating a potential link to the COVID-19 injections.
It is important to acknowledge that these gene therapy products were distributed and administered under the guise of vaccines. The manipulation, coercion, and deception used to promote these products as a solution to the pandemic are deeply troubling. The revelation that these products were known to have harmful effects raises questions about the motives behind their widespread administration.
In conclusion, the analysis of FDA documents has revealed disturbing information about the COVID-19 gene therapy products marketed as vaccines. The evidence suggests that these products have the potential to shed, cause cancer, and harm individuals who did not consent to gene therapy. The implications of these findings are significant and warrant further investigation into the true nature of these products and the actions of regulatory agencies.
